Synaptopathy in CHMP2B frontotemporal dementia highlights the synaptic vesicle cycle as a therapeutic target
Main Authors: | Miranda Robbins, Emma L Clayton |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Neural Regeneration Research |
Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=2;spage=315;epage=316;aulast=Robbins |
Similar Items
-
Cortical Frontoparietal Network Dysfunction in CHMP2B-Frontotemporal Dementia
by: Christian Sandøe Musaeus, et al.
Published: (2021-09-01) -
Neuroprotective activity of ursodeoxycholic acid in CHMP2BIntron5 models of frontotemporal dementia
by: Ryan J.H. West, et al.
Published: (2020-10-01) -
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B
by: Yu Zhang, et al.
Published: (2017-03-01) -
Endo‐lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation
by: Anders Toft, et al.
Published: (2023-01-01) -
Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation
by: Clayton, E, et al.
Published: (2017)